II
RCUS icon

Inspire Investing’s Arcus Biosciences RCUS Stock Holding History

Inspire Investing’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26 Sell
1
-1
-50% -$22 ﹤0.01% 1090
2025
Q4 		$45 Buy
+2
New +$41 ﹤0.01% 1080
2023
Q3 		– Sell
-15,318
Closed -$311K – 867
2023
Q2 		$311K Buy
15,318
+366
+2% +$6.97K 0.04% 766
2023
Q1 		$273K Buy
14,952
+3,531
+31% +$67.5K 0.03% 633
2022
Q4 		$236K Buy
11,421
+3,534
+45% +$97.2K 0.03% 458
2022
Q3 		$206K Buy
+7,887
New +$209K 0.03% 654

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Inspire Investing's RCUS Position: Q1 2026 in Review

Inspire Investing reduced its Arcus Biosciences (RCUS) stake by 50% in Q1 2026, selling an estimated $22 and leaving 1 share worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Inspire Investing first reported a position in RCUS in Q3 2022 and has held it in 6 quarters since. The position peaked at $311K in Q2 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Inspire Investing held 1 share of Arcus Biosciences worth $26 as of Q1 2026.
  • Inspire Investing sold 1 Arcus Biosciences share in Q1 2026, an estimated $22.
  • Arcus Biosciences made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #1090 holding.
  • Inspire Investing first reported a position in Arcus Biosciences in Q3 2022 and has held it in 6 quarters since.
  • Inspire Investing's Arcus Biosciences position peaked at $311K in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.